Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty

NCT06904703 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-04-01

No results posted yet for this study

Summary

This study will be conducted to evaluate the effect of pericapsular nerve group and erector spinae plane block as adjuvants to general anesthesia in geriatrics undergoing total hip arthroplasty.

Conditions

  • Pericapsular Nerve
  • Lumbar Erector Spinae Plane Blocks
  • Geriatrics
  • Total Hip Arthroplasty
  • General Anesthesia

Interventions

DRUG

General anesthesia

Patients will receive general anesthesia.

DRUG

Bupivacaine 0.5%

Patients will receive general anesthesia and erector spinae plane block.

DRUG

Bupivacaine 0.5%

Patients will receive general anesthesia and erector spinae plane block with pericapsular nerve block.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2026-11-01
Completion
2026-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06904703 on ClinicalTrials.gov